CTS (NYSE:CTS) Stock, Quote.Headers.trade-ideas

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan and other countries.

News

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

COOP

CSTM

GOOG

MANH

MSFT

NAVI

SPOT

TNET

UMBF

U.S. stocks closed mostly lower on Wednesday, with the Nasdaq Composite dropping over 200 points. Here is the list of some big stocks recording losses in the previous session.

Boeing, Seagate, Chipotle And Other Big Losers From Wednesday

Penny Stocks

ADXN

AGYS

ARBK

ARVN

CIFR

COSM

New Oriental Education & Technology Group

EMAN

ENPH

EPIX

Sunrise New Energy Co., Ltd - Ordinary Shares

EPOW

EQOS

FEMY

FNHC

FRGT

GOVX

HCTI

HYPR

LMAO

LYLT

MNSO

MRUS

NRGV

OCFT

REVB

RNAZ

SBET

SINT

SMTS

STRY

TCDA

TENB

THMO

TPHS

TSHA

USEA

VAPO

VENA

YMAB

CDIO

Gainers


	ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate Cancer Foundation Scientific Retreat.


Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday

Intraday Update

BPTS

GRNT

Gainers


	ESSA Pharma Inc. (NASDAQ: EPIX) shares surged 59.3% to $2.7417 after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate Cancer Foundation Scientific Retreat.


Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday&#39;s Mid-Day Session

CTS Corp

CONVERGE TECH SLTN CORP by Converge Technology Solutions Corporation

Converge Technology Solutions Corp

Cognizant Technology Solutions Corporation - Class A Common Stock

Cognizant Technology Solutions Corp

CTSI - United States Dollar

CytoSorbents Corp

CTS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTS#NYSE">CTS</a>) reported its Q2 earnings results on Tuesday, July 30, 2024 at 08:00 AM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
CTS beat estimated earnings by 2.0%, reporting an EPS of $0.54 versus an estimate of $0.53.
Revenue was down $15.02 million from the same period last year.
<h3>Previous Earnings Records</h3>
The company beat on EPS by $0.06 in the previous quarter, leading to a 2.0% increase share price change the next day.
Here's a look at CTS's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.53</td>
<td>0.41</td>
<td>0.46</td>
<td>0.56</td>
<td>0.53</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.54</td>
<td>0.47</td>
<td>0.47</td>
<td>0.54</td>
<td>0.59</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>133.38M</td>
<td>126.75M</td>
<td>124.51M</td>
<td>142.07M</td>
<td>146.07M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>130.16M</td>
<td>125.75M</td>
<td>124.69M</td>
<td>134.55M</td>
<td>145.18M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
CTS management provided guidance for FY 2024, expecting earnings between $2.05 and $2.25 per share.
<h3>Competitors that recently released earnings</h3>
When analyzing CTS's numbers, it's imperative to put them into context by comparing them to those of its competitors, like Methode Electronics, RF Industries, and Data I/O.
<ul>
<li>Methode Electronics, earnings announced on July 11, 2024, faced a downturn this quarter. Despite the market's EPS estimate of $-0.2, Methode Electronics disclosed an EPS of $-0.23, resulting in a decrease of -15.0% compared to expectations. This discrepancy could unsettle investors.</li>
<li>RF Industries, earnings revealed on June 13, 2024, exhibited robust performance this quarter. Contrary to the market's projected EPS of $-0.02, RF Industries exceeded expectations with an EPS of $0.01, reflecting an increase of 150.0% compared to estimates. This outcome is likely to gain investor confidence</li>
<li>Data I/O announced earnings on July 25, 2024, revealing results below market expectations. Despite the market's anticipation of an EPS of $-0.01, Data I/O's actual EPS was $-0.09, resulting in a -800.0% decrease compared to expectations.</li>
</ul>
<h3>In-depth Analysis: Competitors' Quarterly Earnings and Stock Performance</h3>
The provided analysis offers insights into the market's response to the latest earnings releases of key competitors. It highlights the expected and announced earnings per share (EPS) for each company, along with their corresponding stock prices at the close of the announcement day and the open of the following trading day.

<table>
<thead>
<tr>
<th>Company Name</th>
<th>Date</th>
<th style="text-align: right;">EPS Expected</th>
<th style="text-align: right;">EPS Announced</th>
<th>EPS Change Percent</th>
<th>Stock Price At Close</th>
<th>Stock Price at Next Day Open</th>
<th>Price Change Percent</th>
</tr>
</thead>
<tbody>
<tr>
<td>CTS</td>
<td>July 30, 2024</td>
<td style="text-align: right;">0.53</td>
<td style="text-align: right;">0.54</td>
<td>1.89%</td>
<td>$47.89</td>
<td>$48.24</td>
<td>0.73%</td>
</tr>
<tr>
<td>Methode Electronics</td>
<td>July 11, 2024</td>
<td style="text-align: right;">-0.20</td>
<td style="text-align: right;">-0.23</td>
<td>-15.0%</td>
<td>$13.62</td>
<td>$13.8</td>
<td>1.32%</td>
</tr>
<tr>
<td>RF Industries</td>
<td>June 13, 2024</td>
<td style="text-align: right;">-0.02</td>
<td style="text-align: right;">0.01</td>
<td>150.0%</td>
<td>$3.2</td>
<td>$3.21</td>
<td>0.31%</td>
</tr>
<tr>
<td>Data I/O</td>
<td>July 25, 2024</td>
<td style="text-align: right;">-0.01</td>
<td style="text-align: right;">-0.09</td>
<td>-800.0%</td>
<td>$2.79</td>
<td>$2.67</td>
<td>-4.3%</td>
</tr>
</tbody>
</table>

<h3>Comparative Assessment: Estimated in Comparison with Actual Peer Revenues</h3>
Here is a comparison table showing estimated and announced revenue figures for CTS's peers. This comparison offers insights into the revenue performance of these companies, giving valuable context for understanding their financial standing within the industry.

<table>
<thead>
<tr>
<th>Company Name</th>
<th>Estimated Revenue</th>
<th>Announced Revenue</th>
<th>Revenue Surprise Percentage</th>
</tr>
</thead>
<tbody>
<tr>
<td>CTS</td>
<td>133.38M</td>
<td>130.16M</td>
<td>-2.41%</td>
</tr>
<tr>
<td>Methode Electronics</td>
<td>264.04M</td>
<td>277.30M</td>
<td>5.02%</td>
</tr>
<tr>
<td>RF Industries</td>
<td>16.28M</td>
<td>16.11M</td>
<td>-1.04%</td>
</tr>
<tr>
<td>Data I/O</td>
<td>6.31M</td>
<td>5.06M</td>
<td>-19.78%</td>
</tr>
</tbody>
</table>

To track all earnings releases for CTS <a href="https://www.benzinga.com/quote/CTS/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

CTS Q2 Earnings Assessment

Given the more moderate growth expectations in the second half of 2024, CTS is updating its&nbsp;guidance&nbsp;for full year 2024 sales to be in the range of&nbsp;$525&nbsp;-&nbsp;$540 million&nbsp;and adjusted diluted EPS to be in the range of&nbsp;$2.05&nbsp;-&nbsp;$2.25, including the expected impact from the SyQwest acquisition.

Guidance

CTS Corporation Sees FY24 Adjusted Diluted EPS To Be In Range Of $2.05-$2.25 Vs. $2.24 Est (Prior View: $2.10-$2.35)

CTS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTS#NYSE">CTS</a>) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.53 by 1.89 percent. This is a 8.47 percent decrease over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $130.16 million which missed the analyst consensus estimate of $133.38 million by 2.41 percent. This is a 10.35 percent decrease over sales of $145.18 million the same period last year.

Earnings Beats

Earnings Misses

CTS Q2 Adj $0.54 Beats $0.53 Estimate, Sales $130.16M Miss $133.38M Estimate

CTS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTS#NYSE">CTS</a>) released its Q1 earnings on Wednesday, May 1, 2024 at 08:00 AM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
CTS beat estimated earnings by 15.0%, reporting an EPS of $0.47 versus an estimate of $0.41.
Revenue was down $20.24 million from the same period last year.
<h3>Past Earnings Performance</h3>
The company beat on EPS by $0.01 in the previous quarter, leading to a 7.000000000000001% drop share price change the next day.
Here's a look at CTS's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.41</td>
<td>0.46</td>
<td>0.56</td>
<td>0.53</td>
<td>0.58</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.47</td>
<td>0.47</td>
<td>0.54</td>
<td>0.59</td>
<td>0.61</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>126.75M</td>
<td>124.51M</td>
<td>142.07M</td>
<td>146.07M</td>
<td>142.84M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>125.75M</td>
<td>124.69M</td>
<td>134.55M</td>
<td>145.18M</td>
<td>145.99M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
CTS management provided guidance for FY 2024, expecting earnings between $2.1 and $2.35 per share.
<h3>Competitors that recently released earnings</h3>
With CTS's earnings data now available, it's crucial to gauge how its competitors, including Kimball Electronics, and Methode Electronics, have been performing.
<ul>
<li>Kimball Electronics reported earnings on May 07, 2024 that fell short of expectations, with an actual EPS of $0.34 compared to the market's estimate of $0.4, resulting in a -15.0% decrease.</li>
<li>Despite market projections of an EPS of $0.09, Methode Electronics's earnings on March 07, 2024 fell short with an actual EPS of $-0.33, representing a -466.67% decrease from expectations.</li>
</ul>
<h3>Insights: Competitors' Quarterly Earnings and Stock Performance</h3>
In this detailed analysis, insights are provided into the market's response to the latest earnings releases of key competitors. It highlights the expected and announced earnings per share (EPS) for each company, along with their corresponding stock prices at the close of the announcement day and the open of the following trading day.

<table>
<thead>
<tr>
<th>Company Name</th>
<th>Date</th>
<th style="text-align: right;">EPS Expected</th>
<th style="text-align: right;">EPS Announced</th>
<th>EPS Change Percent</th>
<th>Stock Price At Close</th>
<th>Stock Price at Next Day Open</th>
<th>Price Change Percent</th>
</tr>
</thead>
<tbody>
<tr>
<td>CTS</td>
<td>May 1, 2024</td>
<td style="text-align: right;">0.41</td>
<td style="text-align: right;">0.47</td>
<td>14.63%</td>
<td>$47.42</td>
<td>$47.9</td>
<td>1.01%</td>
</tr>
<tr>
<td>Kimball Electronics</td>
<td>May 07, 2024</td>
<td style="text-align: right;">0.40</td>
<td style="text-align: right;">0.34</td>
<td>-15.0%</td>
<td>$22.16</td>
<td>$20.52</td>
<td>-7.4%</td>
</tr>
<tr>
<td>Methode Electronics</td>
<td>March 07, 2024</td>
<td style="text-align: right;">0.09</td>
<td style="text-align: right;">-0.33</td>
<td>-466.67%</td>
<td>$14.49</td>
<td>$14.51</td>
<td>0.14%</td>
</tr>
</tbody>
</table>

<h3>Comparative Study: Estimated vs. Actual Peer Revenues</h3>
The table below illustrates a comparison of estimated and announced revenue figures for CTS's peers. This comparison sheds light on the revenue performance of these companies, providing valuable context to understand their financial standing within the industry.

<table>
<thead>
<tr>
<th>Company Name</th>
<th>Estimated Revenue</th>
<th>Announced Revenue</th>
<th>Revenue Surprise Percentage</th>
</tr>
</thead>
<tbody>
<tr>
<td>CTS</td>
<td>126.75M</td>
<td>125.75M</td>
<td>-0.79%</td>
</tr>
<tr>
<td>Kimball Electronics</td>
<td>440.20M</td>
<td>425.04M</td>
<td>-3.44%</td>
</tr>
<tr>
<td>Methode Electronics</td>
<td>287.80M</td>
<td>259.50M</td>
<td>-9.83%</td>
</tr>
</tbody>
</table>

To track all earnings releases for CTS <a href="https://www.benzinga.com/quote/CTS/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CTS Earnings Review: Q1 Summary

<h3>Companies Reporting Before The Bell</h3>
&bull; CTS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTS#NYSE">CTS</a>) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
&bull; Foot Locker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) is likely to report quarterly earnings at $0.32 per share on revenue of $2.28 billion.
&bull; JD.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) is likely to report quarterly earnings at $0.63 per share on revenue of $42.16 billion.
&bull; Super Group (SGHC) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGHC#NYSE">SGHC</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $326.63 million.
&bull; Sotherly Hotels (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOHO#NASDAQ">SOHO</a>) is projected to report earnings for its fourth quarter.
&bull; Thor Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THO#NYSE">THO</a>) is estimated to report quarterly earnings at $0.67 per share on revenue of $2.27 billion.
&bull; Nexxen International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEXN#NASDAQ">NEXN</a>) is expected to report quarterly earnings at $0.10 per share on revenue of $86.80 million.
&bull; VersaBank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VBNK#NASDAQ">VBNK</a>) is likely to report quarterly earnings at $0.35 per share on revenue of $22.43 million.
&bull; Abercrombie &amp; Fitch (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) is expected to report quarterly earnings at $2.83 per share on revenue of $1.43 billion.
&bull; Brown Forman Inc Class B Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) is expected to report quarterly earnings at $0.56 per share on revenue of $1.12 billion.
&bull; WAVE Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WVE#NASDAQ">WVE</a>) is likely to report quarterly loss at $0.23 per share on revenue of $19.86 million.
&bull; Yatsen Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YSG#NYSE">YSG</a>) is projected to report earnings for its fourth quarter.
&bull; iShares $ Short Duration Corp Bond UCITS ETF USD (Dist) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDIG#NASDAQ">SDIG</a>) is projected to report quarterly loss at $0.98 per share on revenue of $22.21 million.
&bull; InspireMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSPR#NASDAQ">NSPR</a>) is expected to report quarterly loss at $0.19 per share on revenue of $1.63 million.
&bull; Korn Ferry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFY#NYSE">KFY</a>) is estimated to report quarterly earnings at $0.99 per share on revenue of $658.50 million.
&bull; Kamada (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KMDA#NASDAQ">KMDA</a>) is projected to report quarterly earnings at $0.05 per share on revenue of $37.71 million.
&bull; PureCycle Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) is projected to report quarterly loss at $0.23 per share on revenue of $180 thousand.
&bull; Xeris Biopharma Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XERS#NASDAQ">XERS</a>) is estimated to report quarterly loss at $0.10 per share on revenue of $43.55 million.
&bull; Genius Sports (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GENI#NYSE">GENI</a>) is expected to report quarterly loss at $0.07 per share on revenue of $126.13 million.
&bull; Adaptimmune Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAP#NASDAQ">ADAP</a>) is estimated to report quarterly loss at $0.10 per share on revenue of $20.47 million.
&bull; NeueHealth (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEUE#NYSE">NEUE</a>) is estimated to report quarterly loss at $4.16 per share on revenue of $283.44 million.
&bull; Campbell Soup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NYSE">CPB</a>) is projected to report quarterly earnings at $0.77 per share on revenue of $2.44 billion.
&bull; EVgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGO#NASDAQ">EVGO</a>) is projected to report quarterly loss at $0.18 per share on revenue of $44.03 million.
&bull; Hippo Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIPO#NYSE">HIPO</a>) is estimated to report quarterly loss at $2.01 per share on revenue of $55.25 million.
&bull; BrainsWay (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWAY#NASDAQ">BWAY</a>) is expected to report quarterly loss at $0.01 per share on revenue of $8.42 million.
&bull; Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) is estimated to report quarterly loss at $0.40 per share on revenue of $1.75 million.
&bull; European Wax Center (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWCZ#NASDAQ">EWCZ</a>) is projected to report quarterly earnings at $0.07 per share on revenue of $54.08 million.
&bull; REV Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REVG#NYSE">REVG</a>) is likely to report quarterly earnings at $0.15 per share on revenue of $579.42 million.
&bull; United Natural Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNFI#NYSE">UNFI</a>) is likely to report quarterly loss at $0.01 per share on revenue of $7.87 billion.
&bull; Berry Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRY#NASDAQ">BRY</a>) is projected to report quarterly earnings at $0.24 per share on revenue of $182.37 million.
&bull; Brown Forman Inc Class A Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) is estimated to report earnings for its third quarter.
&bull; Trinity Cap (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIN#NASDAQ">TRIN</a>) is estimated to report quarterly earnings at $0.54 per share on revenue of $46.42 million.
&bull; Antero Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AR#NYSE">AR</a>) is expected to report earnings for its fourth quarter.
<h3>Companies Reporting After The Bell</h3>
&bull; Descartes Systems Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSGX#NASDAQ">DSGX</a>) is likely to report quarterly earnings at $0.37 per share on revenue of $144.29 million.
&bull; Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) is estimated to report quarterly loss at $0.19 per share on revenue of $293.53 million.
&bull; Fortuna Silver Mines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSM#NYSE">FSM</a>) is estimated to report quarterly earnings at $0.10 per share on revenue of $261.00 million.
&bull; Inovio Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) is estimated to report quarterly loss at $1.27 per share on revenue of $340 thousand.
&bull; Companhia Siderurgica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SID#NYSE">SID</a>) is likely to report quarterly earnings at $0.19 per share on revenue of $2.32 billion.
&bull; Global X Silver Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIL#NYSE">SIL</a>) is expected to report quarterly earnings at $0.10 per share on revenue of $44.09 million.
&bull; TDCX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDCX#NYSE">TDCX</a>) is expected to report quarterly earnings at $0.09 per share on revenue of $121.92 million.
&bull; Vermilion Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VET#NYSE">VET</a>) is expected to report quarterly earnings at $0.52 per share on revenue of $440.69 million.
&bull; VSE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSEC#NASDAQ">VSEC</a>) is expected to report quarterly earnings at $0.75 per share on revenue of $234.91 million.
&bull; Victoria&#39;s Secret (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) is projected to report quarterly earnings at $2.47 per share on revenue of $2.09 billion.
&bull; SandRidge Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SD#NYSE">SD</a>) is likely to report earnings for its fourth quarter.
&bull; CPS Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPSH#NASDAQ">CPSH</a>) is projected to report earnings for its fourth quarter.
&bull; Grove Collaborative Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GROV#NYSE">GROV</a>) is expected to report quarterly loss at $0.23 per share on revenue of $61.45 million.
&bull; KLX Energy Services Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLXE#NASDAQ">KLXE</a>) is projected to report quarterly earnings at $0.01 per share on revenue of $212.97 million.
&bull; Culp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CULP#NYSE">CULP</a>) is likely to report quarterly loss at $0.16 per share on revenue of $59.49 million.
&bull; GEN Restaurant Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GENK#NASDAQ">GENK</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $43.95 million.
&bull; MISTRAS Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MG#NYSE">MG</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $174.28 million.
&bull; IDT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDT#NYSE">IDT</a>) is projected to report earnings for its second quarter.
&bull; FRP Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPH#NASDAQ">FRPH</a>) is projected to report earnings for its fourth quarter.
&bull; Global Water Resources (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWRS#NASDAQ">GWRS</a>) is estimated to report quarterly earnings at $0.05 per share on revenue of $12.00 million.
&bull; NeoGames (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGMS#NASDAQ">NGMS</a>) is projected to report quarterly loss at $0.07 per share on revenue of $54.53 million.
&bull; Hamilton Beach Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HBB#NYSE">HBB</a>) is estimated to report earnings for its fourth quarter.
&bull; Amplify Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPY#NYSE">AMPY</a>) is likely to report quarterly earnings at $0.18 per share on revenue of $76.22 million.
&bull; Pampa Energia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAM#NYSE">PAM</a>) is likely to report quarterly loss at $0.09 per share on revenue of $421.19 million.
&bull; Talphera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLPH#NASDAQ">TLPH</a>) is estimated to report quarterly loss at $0.20 per share on revenue of $280 thousand.
&bull; Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) is expected to report quarterly loss at $0.12 per share on revenue of $70 thousand.
&bull; HighPeak Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HPK#NASDAQ">HPK</a>) is expected to report quarterly earnings at $0.65 per share on revenue of $339.52 million.
&bull; BRC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRCC#NYSE">BRCC</a>) is estimated to report quarterly loss at $0.01 per share on revenue of $123.75 million.
&bull; MDxHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXH#NASDAQ">MDXH</a>) is likely to report quarterly loss at $0.11 per share on revenue of $18.14 million.
&bull; NACCO Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NC#NYSE">NC</a>) is estimated to report earnings for its fourth quarter.
&bull; Enhabit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHAB#NYSE">EHAB</a>) is expected to report quarterly earnings at $0.03 per share on revenue of $260.16 million.
&bull; Intrepid Potash (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) is projected to report quarterly loss at $0.06 per share on revenue of $43.57 million.
&bull; OneSpan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSPN#NASDAQ">OSPN</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $58.26 million.
&bull; Honest Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNST#NASDAQ">HNST</a>) is estimated to report quarterly loss at $0.08 per share on revenue of $84.14 million.
&bull; SilverCrest Metals (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SILV#AMEX">SILV</a>) is expected to report quarterly earnings at $0.10 per share on revenue of $44.09 million.
&bull; AudioEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEYE#NASDAQ">AEYE</a>) is estimated to report quarterly loss at $0.11 per share on revenue of $7.93 million.
&bull; comScore (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCOR#NASDAQ">SCOR</a>) is likely to report quarterly earnings at $0.20 per share on revenue of $97.69 million.
&bull; Viemed Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMD#NASDAQ">VMD</a>) is projected to report quarterly earnings at $0.10 per share on revenue of $50.00 million.
&bull; Kewaunee Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KEQU#NASDAQ">KEQU</a>) is projected to report earnings for its third quarter.
&bull; ChromaDex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXC#NASDAQ">CDXC</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $20.98 million.
&bull; Whitestone REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSR#NYSE">WSR</a>) is projected to report earnings for its fourth quarter.
&bull; Aris Water Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARIS#NYSE">ARIS</a>) is estimated to report earnings for its fourth quarter.
&bull; OrthoPediatrics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KIDS#NASDAQ">KIDS</a>) is expected to report quarterly loss at $0.28 per share on revenue of $37.73 million.
&bull; Invesco National AMT-Free Municipal Bond ETFo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PZA#NYSE">PZA</a>) is estimated to report earnings for its fourth quarter.
&bull; Hudson Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HDSN#NASDAQ">HDSN</a>) is projected to report quarterly earnings at $0.08 per share on revenue of $40.28 million.
&bull; Stabilis Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNG#NASDAQ">SLNG</a>) is projected to report earnings for its fourth quarter.
&bull; Airgain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRG#NASDAQ">AIRG</a>) is projected to report quarterly loss at $0.20 per share on revenue of $10.00 million.
&bull; Finance of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOA#NYSE">FOA</a>) is projected to report quarterly loss at $0.08 per share on revenue of $63.22 million.
&bull; Yext (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YEXT#NYSE">YEXT</a>) is likely to report quarterly earnings at $0.07 per share on revenue of $100.24 million.
&bull; TriplePoint Venture Gwth (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPVG#NYSE">TPVG</a>) is expected to report quarterly earnings at $0.48 per share on revenue of $33.13 million.
&bull; CompoSecure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPO#NASDAQ">CMPO</a>) is estimated to report quarterly earnings at $0.23 per share on revenue of $96.49 million.
&bull; Kodiak Gas Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGS#NYSE">KGS</a>) is expected to report quarterly earnings at $0.29 per share on revenue of $222.52 million.
&bull; Cyber Hornet S&amp;P 500 and Bitcoin 75/25 Strategy ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZZZ#NASDAQ">ZZZ</a>) is likely to report quarterly earnings at $0.53 per share on revenue of $247.43 million.
&bull; Ellington Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EARN#NYSE">EARN</a>) is projected to report quarterly earnings at $0.23 per share on revenue of $2.46 million.
&bull; Spire Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPIR#NYSE">SPIR</a>) is expected to report quarterly loss at $0.72 per share on revenue of $29.34 million.
&bull; Lulus Fashion Lounge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVLU#NASDAQ">LVLU</a>) is estimated to report quarterly loss at $0.10 per share on revenue of $73.40 million.
&bull; Rush Street Interactive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSI#NYSE">RSI</a>) is likely to report quarterly loss at $0.03 per share on revenue of $178.56 million.
&bull; Hamilton Insurance Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HG#NYSE">HG</a>) is expected to report quarterly earnings at $0.65 per share on revenue of $15.30 million.
&bull; Infinera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INFN#NASDAQ">INFN</a>) is likely to report quarterly earnings at $0.09 per share on revenue of $437.34 million.
&bull; Riley Exploration Permian (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/REPX#AMEX">REPX</a>) is estimated to report quarterly earnings at $1.60 per share on revenue of $94.75 million.
&bull; Zymeworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYME#NASDAQ">ZYME</a>) is expected to report quarterly loss at $0.43 per share on revenue of $15.45 million.
&bull; Miller Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLR#NYSE">MLR</a>) is projected to report earnings for its fourth quarter.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

ADAP

AEYE

AIRG

AMPY

ARIS

BRCC

BWAY

CDXC

CMPO

CPSH

CULP

DSGX

EARN

EHAB

EVGO

EWCZ

FRPH

GENI

GENK

GROV

GWRS

HDSN

HIPO

HNST

HTOO

INFN

KEQU

KIDS

KLXE

KMDA

LVLU

MDXH

NEUE

NEXN

NGMS

NSPR

OSPN

PowerShares Insured Municipal Bond Portfolio

REPX

REVG

SCOR

SDIG

SGHC

SILV

SLNG

SOHO

SPIR

TDCX

TLPH

TPVG

TRIN

UNFI

VBNK

VSCO

VSEC

XERS

YEXT

ZYME

Earnings Scheduled For March 6, 2024

Sidoti &amp; Co. analyst John Franzreb downgrades CTS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTS#NYSE">CTS</a>) from Buy to Neutral and announces $46 price target.

Downgrades

Price Target

Analyst Ratings

Sidoti & Co. Downgrades CTS to Neutral, Announces $46 Price Target

WIIM

CTS shares are trading higher after the company reported better-than-expected Q4 financial results, issued 2024 guidance and announced a $100 million share repurchase program.

CTS Expects A Soft First Half, And An Improving Trend In Second Half Of 2024

CTS Expects 2024 Sales Of $530M-$570M (Est. $550.358M), Adjusted EPS Of $2.10-$2.35 (Est. $2.29)

CTS also announced that its Board of Directors approved a new share repurchase program that authorizes the company to repurchase up to&nbsp;$100 million&nbsp;of its common stock, replacing the existing program authorized in February 2023. The new share repurchase program has no scheduled termination date.

Buybacks

CTS Plans $100M Share Repurchase Program, Replacing Existing Program Authorized In February 2023

CTS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTS#NYSE">CTS</a>) reported quarterly Adj earnings of $0.47 per share which beat the analyst consensus estimate of $0.46 by 2.17 percent. This is a 16.07 percent decrease over earnings of $0.56 per share from the same period last year. The company reported quarterly sales of $124.69 million which beat the analyst consensus estimate of $124.51 million by 0.15 percent. This is a 12.36 percent decrease over sales of $142.28 million the same period last year.

CTS Q4 Adj EPS $0.47 Beats $0.46 Estimate, Sales $124.69M Beat $124.51M Estimate

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

CTS

CTS (CTS) Forecast

CTS (NYSE:CTS) Stock, Quote.Headers.trade-ideas